Grant opportunity · Food and Drug Administration

Studies Addressing Rare Neurodegenerative Diseases including ALS

Award amount varies

About this opportunity

The purpose of this funding opportunity announcement (FOA) is to support studies that advance medical product development of interventions intended to prevent, diagnose, mitigate, treat, or cure ALS and other rare neurodegenerative diseases in adults and children. Through the support of these studies, FDA expects to address critical knowledge gaps, exert a significant impact on rare neurodegenerative diseases, and to inform current or future product development.

Who may apply

Special district governments, Native American tribal organizations (other than Federally recognized tribal governments), Independent school districts, Public and State controlled institutions of higher education, Private institutions of higher education, State governments, Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility", County governments, Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, For profit organizations other than small businesses, Small businesses, Public housing authorities/Indian housing authorities, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Native American tribal governments (Federally recognized), City or township governments

Deadline

See program details

Browse grant details for free. Check the official program requirements before applying.